Holen Sie sich die Stockscreener-App
0.2727
2.87%
0.0076
Schlusskurs vom Vortag:
$0.2651
Offen:
$0.2666
24-Stunden-Volumen:
348.14K
Relative Volume:
0.96
Marktkapitalisierung:
$26.48M
Einnahmen:
$1.20M
Nettoeinkommen (Verlust:
$-5.34M
KGV:
-4.4126
EPS:
-0.0618
Netto-Cashflow:
$-6.27M
1W Leistung:
+6.73%
1M Leistung:
-4.62%
6M Leistung:
-32.67%
1J Leistung:
+1.00%
1-Tages-Spanne:
$0.261
$0.2776
1-Wochen-Bereich:
$0.255
$0.2868
52-Wochen-Spanne:
$0.242
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Firmenname
IGC Pharma Inc
Sektor
Branche
Telefon
301-983-0998
Adresse
4336 Montgomery Avenue, Bethesda, MD
Compare IGC vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.268 | 26.19M | 1.20M | -5.34M | -6.27M | -0.0618 |
VRTX
Vertex Pharmaceuticals Inc
|
433.68 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.51 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.60 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
331.03 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.76 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
IGC Pharma (IGC) price target increased by 10.34% to 4.08 - MSN
IGC.WS (India Globalization Capital) PB Ratio : (As of Apr. 03, 2026) - GuruFocus
IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
How does IGC Pharma Inc perform in inflationary periodsWeekly Gains Report & Technical Buy Zone Confirmations - baoquankhu1.vn
IGC Pharma Launches Strategic National Media Partnership with Ne - gurufocus.com
Aug Breakouts: Should I trade or invest in IGC Pharma Inc2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
IGC Pharma Launches National Media Partnership to Boost Visibility - TipRanks
Signal Recap: What is IGC Pharma Incs valuation compared to sectorQuarterly Portfolio Review & Comprehensive Market Scan Insights - baoquankhu1.vn
Performance Recap: What is IGC Pharma Incs book value per shareMarket Growth Review & Stock Market Timing Techniques - baoquankhu1.vn
IGC Pharma launches 12-part national media campaign with New to The Street to boost investor awareness - TradingView
IGC Pharma (NYSE: IGC) inks 12-part New to The Street deal - Stock Titan
Aug Shorts: What is IGC Pharma Incs book value per share2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
IGC Pharma Partners with New to The Street for National Media Campaign - National Today
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - biospace.com
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - MSN
IGC Pharma, New to The Street launch 12-part national media partnership - Yahoo Finance
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning - Corsicana Daily Sun
Macro Review: Is IGC Pharma Inc likely to announce a buybackChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
If You Invested $1,000 in IGC Pharma Inc (IGC) - Stock Titan
Growth Report: Does IGC Pharma Inc stock benefit from AI growthEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Ascendiant Capital maintains IGC Pharma (IGC) buy recommendation - MSN
Fund Flows: Can IGC Pharma Inc ride the EV wave2026 PreEarnings & Daily Technical Stock Forecast Reports - baoquankhu1.vn
India Globalization Capital, Inc.: Fundamental Analysis and Financial Ratings | IGC | US45408X3089 - marketscreener.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Hastings Tribune
IGC Achieves Major Milestone in Alzheimer's Trial Amid Financial Loss - GuruFocus
IGC Pharma’s AI-Driven Innovations and Patent Portfolio for Alzheimer’s Disease and Neuropsychiatric Treatments - Minichart
IGC to Showcase AI Platform for Alzheimer's Research at 2026 Con - GuruFocus
IGC Pharma : Annual Transition Report (Form 10-KT) - marketscreener.com
IGC Pharma (IGC) Transition 10-KT: CALMA Phase 2 shows interim agitation improvements - Stock Titan
IGC Pharma to Showcase AI Platform with Alzheimer’s Disease Data Initiative at ADPD 2026 - BioSpace
IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026 - PharmiWeb.com
IGC Pharma to Showcase AI Platform With Alzheimer's Disease Data Initiative at ADPD 2026 - 富途牛牛
CEO Change: What is the Moat Score of IGC Pharma IncMarket Activity Recap & Real-Time Volume Analysis Alerts - baoquankhu1.vn
IGC Pharma (NYSEAMERICAN:IGC) Stock Price Down 1.2% – Time to Sell? - Defense World
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial - Nasdaq
IGC Pharma Secures New Debt Financing for Liquidity - The Globe and Mail
IGC Pharma Secures ~$526K in Financing, Including Default-Convertible Note With Vanquish - TradingView
IGC Pharma (NYSE: IGC) raises cash via discounted note and $219,000 loan - Stock Titan
How IGC Pharma Inc. stock compares to growth peersDollar Strength & Smart Money Movement Tracker - Naître et grandir
EPS Watch: Should value investors consider IGC Pharma IncJuly 2025 Setups & Fast Momentum Entry Tips - baoquankhu1.vn
IGC Pharma, Inc. announced that it has received $0.307 million in funding - marketscreener.com
IGC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IGC Should I Buy - Intellectia AI
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Suppo - PharmiWeb.com
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research - Nasdaq
Inside IGC Pharma’s AI push to clean up Alzheimer’s data - Stock Titan
IGC PE Ratio & Valuation, Is IGC Overvalued - Intellectia AI
FOMO Trade: What is the Moat Score of IGC Pharma IncBond Market & Verified Momentum Stock Ideas - baoquankhu1.vn
Trend Report: What is the Moat Score of IGC Pharma IncJuly 2025 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets - The Globe and Mail
Finanzdaten der IGC Pharma Inc-Aktie (IGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
IGC Pharma Inc-Aktie (IGC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PRINS RICHARD K | Director |
Jan 19 '26 |
Option Exercise |
0.00 |
100,000 |
0 |
1,371,251 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):